Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0 and now includes 7 locations, replacing the previous version v2.9.7.
    Difference
    0.2%
    Check dated 2024-07-23T14:15:53.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T06:56:54.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.0%
    Check dated 2024-07-02T13:37:50.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study on Immunotherapy followed by EGFR Inhibitor in Locally Advanced or Metastatic Squamous Cell Cancer of the Skin. The update likely includes new information or modifications to the study protocol or details.
    Difference
    0.0%
    Check dated 2024-06-27T09:56:43.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent change in the webpage content related to the study on Immunotherapy followed by EGFR Inhibitor in Locally Advanced or Metastatic Squamous Cell Cancer of the Skin, focusing on the combination treatment strategy with pembrolizumab and cetuximab to tackle primary and secondary resistance.
    Difference
    0.0%
    Check dated 2024-06-26T08:46:29.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Show more' has been updated to 'Show less Show less'. Additionally, the revision has changed to v2.9.1.
    Difference
    15%
    Check dated 2024-06-25T08:29:32.000Z thumbnail image

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.